|
|
|
| | |
| | | | |
organism-gene
|
|
PR:P02743 serum amyloid P-component (human), hAPCS |
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000046352 serum amyloid P-component, signal peptide removed form (human), hAPCS/SigPep- |
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052725 serum amyloid P-component N-glycosylated 1 (human), hAPCS/NGlyco:1 |
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052726 serum amyloid P-component N-glycosylated 2 (human), hAPCS/NGlyco:2 |
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052727 serum amyloid P-component N-glycosylated 3 (human), hAPCS/NGlyco:3 |
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052728 serum amyloid P-component N-glycosylated 4 (human), hAPCS/NGlyco:4 |
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052729 serum amyloid P-component N-glycosylated 5 (human), hAPCS/NGlyco:5 |
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052730 serum amyloid P-component N-glycosylated 6 (human), hAPCS/NGlyco:6 |
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052731 serum amyloid P-component N-glycosylated 7 (human), hAPCS/NGlyco:7 |
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052732 serum amyloid P-component N-glycosylated 8 (human), hAPCS/NGlyco:8 |
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052733 serum amyloid P-component N-glycosylated 9 (human), hAPCS/NGlyco:9 |
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052734 serum amyloid P-component N-glycosylated 10 (human), hAPCS/NGlyco:10 |
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052735 serum amyloid P-component O-glycosylated 1 (human), hAPCS/OGlyco:1 |
|
|
|
|